BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15338189)

  • 1. Antiphospholipid antibodies in children with systemic lupus erythematosus: a prospective study in northern India.
    Ahluwalia J; Singh S; Garewal G
    Rheumatol Int; 2005 Sep; 25(7):530-5. PubMed ID: 15338189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India.
    Ahluwalia J; Singh S; Naseem S; Suri D; Rawat A; Gupta A; Masih J; Bose S
    Rheumatol Int; 2014 May; 34(5):669-73. PubMed ID: 23563494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Incidence of Pulmonary Hypertension in Antiphospholipid Antibody Positive Lupus.
    Ware D; Sharma V; Kalekar L; Kamble A; Mahajan A; Gokhale Y
    J Assoc Physicians India; 2015 Apr; 63(4):17-20. PubMed ID: 26591164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of audiovestibular dysfunction in children with systemic lupus erythematosus.
    Gad GI; Mohamed ST; Awwad KS; Mohamed RF
    Int J Pediatr Otorhinolaryngol; 2013 Sep; 77(9):1561-6. PubMed ID: 23916731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus.
    Male C; Foulon D; Hoogendoorn H; Vegh P; Silverman E; David M; Mitchell L
    Blood; 2005 Dec; 106(13):4152-8. PubMed ID: 16144797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients.
    Alarcón-Segovia D; Delezé M; Oria CV; Sánchez-Guerrero J; Gómez-Pacheco L; Cabiedes J; Fernández L; Ponce de León S
    Medicine (Baltimore); 1989 Nov; 68(6):353-65. PubMed ID: 2811661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
    Molta C; Meyer O; Dosquet C; Montes de Oca M; Babron MC; Danon F; Kaplan C; Clémenceau S; Castellano F; Levy M
    Pediatrics; 1993 Dec; 92(6):849-53. PubMed ID: 8233748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus.
    Gustafsson JT; Gunnarsson I; Källberg H; Pettersson S; Zickert A; Vikerfors A; Möller S; Rönnelid J; Elvin K; Svenungsson E
    Ann Rheum Dis; 2015 Aug; 74(8):1537-43. PubMed ID: 24692586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus.
    Denburg SD; Denburg JA
    Lupus; 2003; 12(12):883-90. PubMed ID: 14714906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
    Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A
    Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus].
    Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G
    Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.